---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-006236"
form_type: "8-K"
ticker: "TPB"
cik: "0001290677"
company_name: "Turning Point Brands, Inc."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:33:25.972267+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Turning Point Brands Q4 net sales up 29% to $121M; Modern Oral surges 266%

## Summary
- Q4 net sales $121.0M (+29.2% YoY); net income $8.2M (+239.8%); adjusted EBITDA $30.0M (+14.4%).
- Modern Oral net sales $41.3M in Q4 (+265.5% YoY); now 34% of total net sales.
- FY 2025 net sales $463.1M (+28.4%); adjusted EBITDA $119.5M (+14.4%); diluted EPS $3.11 vs $2.14.
- FY 2026 guidance: Modern Oral net revenue $180-$190M; Q1 2026 adj. EBITDA expected $24-$27M.
- Stoker's segment Q4 net sales $81.0M (+69.5%); Zig-Zag segment $40.0M (-12.8%).

## SEC filing metadata
- accession: 0001437749-26-006236
- form_type: 8-K
- ticker: TPB
- cik: 0001290677
- company_name: Turning Point Brands, Inc.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1290677/000143774926006236/0001437749-26-006236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1290677/000143774926006236/tpb20260205_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-006236
- JSON: https://secwatch.observer/filing/0001437749-26-006236.json
- Plain text: https://secwatch.observer/filing/0001437749-26-006236.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
